Recently, it was shown that DRG2 knockdown induces Golgi fragmentation [27] and mitochondrial dysfunction [28], decreases the stability of Rac1-positive membrane tubules in cancer cells [29], and suppresses VEGF-A production in melanoma cells, leading to inhibition of tumor angiogenesis [30]. The gene discussed is DRG2; the disease is cancer.